PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB “Super-Stimulation”

Prostate cancer (PCa) is the second leading cause of malignancy-related mortality in males in the Western world. Although treatment like prostatectomy and radiotherapy for localized cancer have good results, similar positive outcomes are not achieved in metastatic PCa. Consequently, these aggressive...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuccolotto, Gaia, Penna, Alessandro, Fracasso, Giulio, Carpanese, Debora, Montagner, Isabella Monia, Dalla Santa, Silvia, Rosato, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511814/
https://www.ncbi.nlm.nih.gov/pubmed/34660275
http://dx.doi.org/10.3389/fonc.2021.708073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8511814/
https://www.ncbi.nlm.nih.gov/pubmed/34660275
http://dx.doi.org/10.3389/fonc.2021.708073

Ejemplares similares